`

Tagged: Regulatory Consulting

BBCR embraces innovative strategy consulting for effective clinical development plan and regulatory strategy. Learn more about BBCR and how we help clients succeed.

April 5th, 2022 | Regulatory Consulting

Our industry needs innovative strategies, and reduced-risk clinical trials. BBCR clinical development services and drug development consulting integrates real world evidence into clinical development plans and regulatory strategies. Focus must go to cost containment and value-based developments that allow sponsors to move more treatments to market faster.  BBCR’s team expertise in rare diseases and precision […]

Drug Repurposing is an enticing market with surging growth forecasts. The orphan class of biological products deserves special attention for drug repurposing as it provides a vital niche to the patient and society and are currently minimally investigated.

March 1st, 2022 | Regulatory Consulting

If you’re interested in learning more about drug repurposing to treat rare disease, BBCR can help with your regulatory consulting needs. We offer expertise in the following areas: FDA meeting and submission Pre-IND integrated development plan Clinical consultant Clinical study design and protocol CRO and project management Study remediation and rescue    

BBCR offers streamlined clinical development and clinical and regulatory expertise to a variety of clients both domestically and internationally.

October 6th, 2021 | Regulatory Consulting

The BBCR team of experts has worked in pre-clinical and clinical product development and regulatory affairs. We believe that understanding the perspective, challenges, and needs of our clients allows us to serve as a trusted adviser throughout the clinical development process. BBCR clients are domestic and international drug and device biotechnology firms as well as […]

Small molecule mediated targeting provides alternative strategies for polypharmacology, systems biology and personalized medicine.

September 7th, 2021 | Regulatory Consulting

Most ongoing research and clinical programs have precision medicine at the core. BBCR can assist in a number of areas in relation to precision medicine, including small molecule research, including: Strategic drug assessment Early Clinical Development Regulatory consultant FDA meeting and submission Pre-IND integrated development plan Clinical consultant Clinical study design and protocol CRO and […]

Boston Biotech Clinical Research specializes in rare disease and works with biotech, pharmaceutical, device companies and investors to streamline the clinical trial process.

July 20th, 2021 | Regulatory Consulting

Our proprietary Strategic Clinical Innovation Organization (SCIO) concept was developed to address and maneuver around evolving challenges, allowing for time and cost efficiencies, and mitigating risk. BBCR works with clients in the areas of Biomarkers, Clinical Research consulting, Regulatory Affairs, and Early Clinical Development. To learn more about how BBCR can help with your research […]

BBCR can help you better understand the role Real World Evidence (RWE) plays for natural history in rare diseases

July 13th, 2021 | Regulatory Consulting

Knowledge of disease and its Natural History is an essential element of any clinical development program. Real-World Data (RWD) is data relating to patient health status and/or the delivery of healthcare routinely collected from a variety of sources. Under the right conditions, data derived from real world sources can be used to build Rare diseases […]

Boston Biotech Clinical Research specializes in rare disease, working with biotech, pharmaceutical, device companies and investors to streamline the clinical trial process.

August 31st, 2020 | Regulatory Consulting

Our experienced team helps each client reach their specific goals by customizing a clinical and regulatory road map of simplified programs and streamlined protocols to meet our clients’ requirements. Click the button below to learn more about how we have helped companies with their clinical trial needs.  

BBCR Streamlines Clinical Development with the Clinical and Regulatory Expertise to Support Your Development Needs

May 28th, 2020 | Regulatory Consulting

BBCR Consulting offers world-class regulatory, clinical research, and biomarker consulting services that provide high-value, and support our clients’ operational and functional needs. Our process is designed to maximize time efficiencies, risk mitigation, and cost savings. We partner with domestic and international, small-to-medium drug and device companies that are entering early clinical development. BBCR is dedicated […]

Pin It on Pinterest